QUOTED. 28 May 2021. Edward Rudd
Juno Capital partner Edward Rudd believes that investing in medtech offers not only a long-term strategy for allocating capital, but an altruistic relief for investors. See what he said about it here.
“In health care, you’ll never get there in one round of funding. It’s several rounds, and there are long lead times. Private capital is well suited because it doesn’t have an institutional lock where a fund needs to be closed in ten years.” – Edward Rudd, partner, Juno Capital
Click here for a free trial of Medtech Insight